Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derek Mittleider

Vascular & Interventional Radiology Cocoa, FL Medical Doctor

NPI 1538234414 CMS profile 435591

2300 State Road 524 Ste 106, Cocoa, FL 32926

Open in the dashboard

General payments

$128,236

266 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derek Mittleider of Cocoa, FL is reported in the CMS Open Payments database as having received $128,236 across 266 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,661 30
2024 General $7,317 23
2023 General $28,908 49
2022 General $36,456 71
2021 General $22,020 41
2020 General $6,994 23
2019 General $14,879 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Mittleider
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Derek Mittleider were reported at $11,661. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Derek Mittleider Vascular & Interventional Radiology median Middle half National median
2019 $14,879 $422 $125–$1,555 $163
2020 $6,994 $200 $68–$652 $114
2021 $22,020 $280 $99–$866 $132
2022 $36,456 $433 $137–$1,497 $149
2023 $28,908 $506 $152–$2,019 $160
2024 $7,317 $556 $175–$1,930 $164
2025 $11,661 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $68,117 141 payments
  2. Inari Medical, Inc. $50,479 67 payments
  3. Bard Peripheral Vascular, Inc. $4,126 7 payments
  4. Stryker Corporation $3,167 2 payments
  5. Cook Medical LLC $386 6 payments
  6. Abbott Laboratories $375 4 payments
  7. Penumbra, Inc. $268 2 payments
  8. AngioDynamics, Inc. $177 4 payments
  9. Nevro Corp. $171 2 payments
  10. Philips Electronics North America Corporation $148 3 payments
  11. Other $821 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $56,719 32 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,975 18 payments
  3. Food and Beverage $12,477 176 payments
  4. Travel and Lodging $12,266 39 payments
  5. Honoraria $3,800 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $54,458 81 payments
  2. CT THROMBECTOMY SYSTEM KIT $52,501 55 payments
  3. General - Therapies $14,403 21 payments
  4. General - Thrombectomy $6,029 7 payments
  5. General Therapies $5,923 6 payments
  6. General - Vascular Intervention General - Vascular Intervention_PI $5,493 12 payments
  7. GENERAL - VASCULAR INTERVENTION Vascular $5,158 7 payments
  8. Venous Wolf $4,586 5 payments
  9. LUTONIX $3,947 2 payments
  10. ANGIOJET $3,595 3 payments
  11. Other $24,055 128 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 232 billing codes

Paid by Medicare

$377,410

Of which drugs: $96

Medicare patients

1,842

Average age 75

Services billed

3,625

1,050 women, 792 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Ischemic heart disease 42%
Diabetes 41%
Chronic kidney disease 41%
COPD 32%
Heart failure 29%
Depression 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, heparin sodium, per 1000 units J1644 Office 24 225 $40
Injection, fentanyl citrate, 0.1 mg J3010 Office 26 55 $38
Injection, midazolam hydrochloride, per 1 mg J2250 Office 27 103 $11

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DefenCath
  • CorMedix Inc. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

266 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record